| Bioactivity | 20S Proteasome-IN-1 is a 26S proteasome inhibitor extracted from patent WO2006128196A2 compound 2. 20S Proteasome-IN-1 has the potential for cancer, immune-related disorders, inflammation, ischemic conditions, neurodegenerative disorders and other diseases research[1]. |
| Name | 20S Proteasome-IN-1 |
| CAS | 858557-69-4 |
| Formula | C23H25N3O4 |
| Molar Mass | 407.46 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Parlati F, et, al. Novel substrate for rpn 11 enzymatic activity. WO2006128196A2. |
20S Proteasome-IN-1
CAS: 858557-69-4 F: C23H25N3O4 W: 407.46
20S Proteasome-IN-1 is a 26S proteasome inhibitor extracted from patent WO2006128196A2 compound 2. 20S Proteasome-IN-1 h
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.